- Pharmaceutical companies
- Europe
- Spain
- Incyte
Incyte in Spain
E-mail: atccliente.138@alloga.es
Address:
-
Alloga Logistics Spain
PI Antonio del Rincón Avda . Industria 102545222 Borox (Toledo)
Phone: +34 925 52 74 54
Other Incyte's locations around the world
Clinical Trials sponsored by Incyte
-
Incyte Biosciences Japan GKReclutamientoLinfoma difuso de células B grandes | Linfoma no HodgkinJapón
-
Incyte Biosciences International SàrlTerminadoNeoplasias malignas avanzadasEstados Unidos
-
Incyte Biosciences International SàrlTerminadoCáncer metastásico | Neoplasias malignas avanzadasEstados Unidos
-
Incyte Biosciences International SàrlTerminadoCáncer de cuello uterino | Carcinoma hepatocelular | Cáncer de esófago | Cáncer de ovarios | Mesotelioma | Cáncer de pulmón de células no pequeñas (CPCNP) | Carcinoma urotelial | Carcinoma de células de Merkel | Linfoma difuso de células B grandes | Cáncer de mama triple negativo | Carcinoma de células renales... y otras condicionesEstados Unidos
-
Incyte Biosciences International SàrlRetiradoLeucemia linfoblástica aguda positiva para BCR-ABLAlemania, Francia, Chequia
-
Incyte Biosciences UKTerminadoLeucemia mielógena crónica en fase acelerada | Leucemia mielógena crónica en fase crónica | Leucemia linfoblástica aguda con cromosoma Filadelfia positivo | Leucemia mielógena crónica en fase blásticaReino Unido, Irlanda
-
Incyte CorporationAún no reclutandoEnfermedad crónica de injerto contra huésped
-
Incyte CorporationReclutamientoHidradenitis supurativa (HS)Estados Unidos, Austria, Bélgica, Canadá, Alemania, Polonia, España, Australia, Dinamarca, Francia, Reino Unido, Japón, Bulgaria, Países Bajos, Chequia, Grecia, Italia
-
Incyte CorporationReclutamientoVitíligo no segmentarioAlemania, Estados Unidos, Italia, Polonia, Canadá, Francia, Bulgaria, Hungría, Reino Unido
-
Incyte CorporationReclutamientoNeoplasias mieloproliferativasEspaña, Japón, Francia, Italia, Alemania, Australia, Reino Unido, Dinamarca, Canadá
About Incyte
Incyte is a global biopharmaceutical company founded on the premise that investment in strong science and the relentless pursuit of R&D excellence can translate into new solutions that can positively affect patients’ lives. Our drug discovery and development efforts were founded in 2002 in Wilmington, Delaware, by a team of research scientists, chemists and biologists working in immunology. Today, we employ approximately 1500 people and have operations in the U.S., Europe and Japan. Our unique expertise in medicinal chemistry and biology have enabled us to create a diversified portfolio of marketed products and clinical candidates, the majority of which were discovered by Incyte scientists. We are advancing a growing pipeline of medicines across two franchises: Oncology and Inflammation & Autoimmunity. The commitment of our talented team of world-class scientists to continued scientific excellence has enabled us to identify new molecules, decipher new pathways and develop first-in-class and best-in-class medicines.